Intermediate Alpha-1 Antitrypsin Deficiency Can Play a Role in Pulmonary Exacerbation?

A. Annunziata, A. Coppola, P. Coni, G. Fiorentino
{"title":"Intermediate Alpha-1 Antitrypsin Deficiency Can Play a Role in Pulmonary Exacerbation?","authors":"A. Annunziata, A. Coppola, P. Coni, G. Fiorentino","doi":"10.12974/2312-5470.2021.07.01","DOIUrl":null,"url":null,"abstract":"Background: Alpha-1 antitrypsin deficiency is generally suspected in young patients with pulmonary emphysema or chronic obstructive pulmonary disease (COPD). Patients often suffer from diagnostic delays or are misdiagnosed, for example, with COPD, asthma, or airway hyperresponsiveness because of the nonspecific nature of respiratory symptoms recognised with Alpha-1 antitrypsin deficiency (AATD). These pathologies develop in homozygous patients (both compromised alleles) with severely deficient protein; however, they are also frequently observed in heterozygous patients (only one compromised allele) for the gene mutation with a more or less deficient protein and functional anatomical damage of varying severity depending on the type of mutation and the exposure to environmental risk factors and/or professional that can trigger the repeated injurious inflammatory process. Case Description: We describe two cases of late diagnosis of alpha-1 antitrypsin deficiency, with many exacerbations and intermediate level of alpha-1 antitrypsin. Due to the peculiar clinical history, and the PLowell rare mutation, although intermediate AATD, the patients were subjected to replacement therapy and they obtained clinical improvement. Discussion: Both the cases carried a heterozygous PLowell mutation representing two interesting and rare examples of clinical cases with double heterozygosity. The presence in the other AAT allele of the S-mutation in the first case and a concomitant presence of another mutation in the cystic fibrosis gene in the second case contributed to the protease-antiprotease imbalance and, despite intermediate AATD, was the probable cause of the numerous exacerbations. Conclusion: Alpha-1 antitrypsin deficiency should always be suspected in patients with respiratory disease and an unclear or complex clinical history. It may be useful to recognize and evaluate treatment even outside the established parameters, in selected cases. ","PeriodicalId":245488,"journal":{"name":"Global Journal of Respiratory Care","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Journal of Respiratory Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12974/2312-5470.2021.07.01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Alpha-1 antitrypsin deficiency is generally suspected in young patients with pulmonary emphysema or chronic obstructive pulmonary disease (COPD). Patients often suffer from diagnostic delays or are misdiagnosed, for example, with COPD, asthma, or airway hyperresponsiveness because of the nonspecific nature of respiratory symptoms recognised with Alpha-1 antitrypsin deficiency (AATD). These pathologies develop in homozygous patients (both compromised alleles) with severely deficient protein; however, they are also frequently observed in heterozygous patients (only one compromised allele) for the gene mutation with a more or less deficient protein and functional anatomical damage of varying severity depending on the type of mutation and the exposure to environmental risk factors and/or professional that can trigger the repeated injurious inflammatory process. Case Description: We describe two cases of late diagnosis of alpha-1 antitrypsin deficiency, with many exacerbations and intermediate level of alpha-1 antitrypsin. Due to the peculiar clinical history, and the PLowell rare mutation, although intermediate AATD, the patients were subjected to replacement therapy and they obtained clinical improvement. Discussion: Both the cases carried a heterozygous PLowell mutation representing two interesting and rare examples of clinical cases with double heterozygosity. The presence in the other AAT allele of the S-mutation in the first case and a concomitant presence of another mutation in the cystic fibrosis gene in the second case contributed to the protease-antiprotease imbalance and, despite intermediate AATD, was the probable cause of the numerous exacerbations. Conclusion: Alpha-1 antitrypsin deficiency should always be suspected in patients with respiratory disease and an unclear or complex clinical history. It may be useful to recognize and evaluate treatment even outside the established parameters, in selected cases. 
中间α -1抗胰蛋白酶缺乏是否在肺恶化中起作用?
背景:α -1抗胰蛋白酶缺乏症通常在肺气肿或慢性阻塞性肺疾病(COPD)的年轻患者中被怀疑。由于α -1抗胰蛋白酶缺乏症(AATD)所识别的呼吸道症状的非特异性,患者常常出现诊断延迟或误诊,例如慢性阻塞性肺病、哮喘或气道高反应性。这些疾病发生在严重缺乏蛋白质的纯合子患者(等位基因均受损);然而,它们也经常在杂合患者(只有一个受损等位基因)中观察到,因为基因突变或多或少存在蛋白质缺陷,并且根据突变类型和暴露于环境风险因素和/或专业因素的不同,功能解剖损伤的严重程度不同,可以触发重复的有害炎症过程。病例描述:我们描述了两个晚期诊断为α -1抗胰蛋白酶缺乏症的病例,有许多恶化和α -1抗胰蛋白酶的中间水平。由于其特殊的临床病史和PLowell罕见的突变,虽然是中度AATD,但患者接受了替代治疗,临床得到改善。讨论:这两个病例都携带一个杂合PLowell突变,代表了两个有趣而罕见的双杂合临床病例。在第一个病例中,s突变的另一个AAT等位基因的存在,以及在第二个病例中,伴随的另一个囊性纤维化基因的突变,导致了蛋白酶-抗蛋白酶失衡,尽管存在中度AATD,但这可能是许多恶化的原因。结论:对于有呼吸道疾病且临床病史不明确或复杂的患者,应始终怀疑α -1抗胰蛋白酶缺乏症。在选定的病例中,即使在既定参数之外,识别和评价治疗也可能是有用的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信